UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of respiratory and critical care medicine, ISSN 1073-449X, 2001, Volume 163, Issue 6, pp. 1371 - 1375
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recurrence | Enterobacteriaceae Infections - diagnosis | Prospective Studies | Humans | Middle Aged | Haemophilus Infections - blood | Male | Pneumococcal Infections - diagnosis | Haemophilus Infections - diagnosis | Pseudomonas Infections - blood | Respiration, Artificial - adverse effects | Time Factors | Pneumonia - diagnosis | Pneumonia - blood | Pneumococcal Infections - etiology | Risk Factors | Enterobacteriaceae Infections - etiology | Pseudomonas Infections - diagnosis | Cross Infection - drug therapy | Pneumococcal Infections - blood | Cross Infection - diagnosis | Bacterial Infections - blood | Cross Infection - blood | Enterobacteriaceae Infections - drug therapy | Practice Guidelines as Topic | Staphylococcal Infections - etiology | Pneumococcal Infections - drug therapy | Pseudomonas Infections - etiology | Cross Infection - etiology | Bacterial Infections - etiology | Infection Control - methods | Haemophilus influenzae | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Adult | Female | Leukocyte Count | Haemophilus Infections - drug therapy | Staphylococcal Infections - blood | Staphylococcal Infections - drug therapy | Pneumonia - etiology | Pseudomonas Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Haemophilus Infections - etiology | Staphylococcal Infections - diagnosis | Pneumonia - drug therapy | Enterobacteriaceae Infections - blood | Aged | Bacterial Infections - diagnosis | Drug Monitoring | Index Medicus | Abridged Index Medicus
Journal Article
Eastern Mediterranean health journal, ISSN 1020-3397, 2019, Volume 25, Issue 2, pp. 90 - 97
Intensive care units | Urinary tract infections | Pneumonia | Catheter-related infections | Drug resistance | Health Care Sciences & Services | Public, Environmental & Occupational Health | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Pseudomonas Infections - etiology | Humans | Middle Aged | Drug Resistance, Bacterial | Intensive Care Units - statistics & numerical data | Male | Pneumonia, Ventilator-Associated - epidemiology | Incidence | Methicillin-Resistant Staphylococcus aureus | Hospitals, Teaching - statistics & numerical data | Enterobacteriaceae Infections - epidemiology | Klebsiella Infections - epidemiology | Female | Acinetobacter Infections - etiology | Catheter-Related Infections - epidemiology | Catheterization, Central Venous - adverse effects | Klebsiella Infections - etiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Risk Factors | Enterobacteriaceae Infections - etiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Cross Infection - microbiology | Iran - epidemiology | Urinary Catheterization - adverse effects | Staphylococcal Infections - etiology | Methicillin | Medical research | Hospital patients | Drug resistance in microorganisms | Bacterial pneumonia | Staphylococcus aureus infections | Medicine, Experimental | Beta lactamases | Health aspects | Infection control | Klebsiella | Health care | Low income groups | Intensive care | Diagnostic tests | Infections | β-Lactamase | Vancomycin | Urinary tract | Epidemiology | Blood | Risk factors | Microorganisms | Piperacillin | Antibiotic resistance | Patient safety | Pseudomonas aeruginosa | Urogenital system | Teaching hospitals | Urine | Ventilators | Ventilator-associated pneumonia | High income | Medical instruments | Staphylococcus infections | Antimicrobial agents | Disease control | Catheters | Urinary tract diseases | Hospitals | Surveillance | Tazobactam | Ampicillin | Ventilation | Sulbactam
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2003, Volume 168, Issue 8, pp. 918 - 951
Cystic fibrosis | Pseudomonas aeruginosa | Airway disease | Antibiotics | Cystic fibrosis transmembrane conductance regulator | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | United States - epidemiology | Pseudomonas Infections - etiology | Humans | Drug Resistance, Bacterial | Infection Control - methods | Pseudomonas Infections - physiopathology | Burkholderia cepacia | Achromobacter | Respiratory Tract Infections - etiology | Respiratory Tract Infections - physiopathology | Stenotrophomonas maltophilia | Pseudomonas Infections - drug therapy | Mucociliary Clearance | Ambulatory Care - methods | Gene Transfer Techniques - trends | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Respiratory Tract Infections - drug therapy | Treatment Outcome | Cystic Fibrosis - complications | Cystic Fibrosis - epidemiology | Respiratory Tract Infections - diagnosis | Cystic Fibrosis - genetics | Burkholderia Infections - drug therapy | Survival Analysis | Cystic Fibrosis - diagnosis | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Chronic Disease | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Transplant international, ISSN 0934-0874, 09/2017, Volume 30, Issue 9, pp. 903 - 913
multidrug resistance | organ transplantation | trends | bacteraemia | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Prospective Studies | Humans | Middle Aged | Male | Organ Transplantation | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Gram-Positive Bacterial Infections - microbiology | Bacteremia - etiology | Adult | Female | Postoperative Complications - drug therapy | Risk Factors | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Postoperative Complications - epidemiology | Gram-Positive Bacterial Infections - etiology | Gram-Positive Bacterial Infections - epidemiology | Postoperative Complications - microbiology | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Aged | Gram-Negative Bacterial Infections - etiology | Gram-Positive Bacterial Infections - drug therapy | Transplantation of organs, tissues, etc | Drug resistance in microorganisms | Beta lactamases | Health aspects | Analysis | Klebsiella | Bacilli | Transplants & implants | Infections | Drug resistance | Empirical analysis | Gram-negative bacilli | Antibiotics | Pseudomonas aeruginosa | Trends | Health risk assessment | Carbapenems | Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 5/2010, Volume 53, Issue 5, pp. 914 - 923
Medicine & Public Health | Human Physiology | Foot infections | Skin and soft tissue infection | Mortality | Metabolic Diseases | MRSA | Hospitalised patients | Internal Medicine | Diabetes | Length of stay | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Pseudomonas Infections - economics | Soft Tissue Infections - etiology | Diabetes Complications - microbiology | Pseudomonas Infections - etiology | Prevalence | Length of Stay - economics | Staphylococcal Skin Infections - epidemiology | Humans | Risk Factors | Soft Tissue Infections - economics | Iatrogenic Disease - economics | Diabetes Complications - economics | Soft Tissue Infections - epidemiology | Diabetes Mellitus - microbiology | Pseudomonas - isolation & purification | Inpatients | Health Care Costs | Diabetes Mellitus - economics | Staphylococcal Skin Infections - etiology | Pseudomonas Infections - epidemiology | Diabetes Complications - epidemiology | Iatrogenic Disease - epidemiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Staphylococcal Skin Infections - economics | Diabetics | Patient outcomes | Diabetic foot | Staphylococcus aureus infections | Risk factors | Medical care, Cost of | Medical colleges | Hospitals | Skin | Foot diseases | Index Medicus
Journal Article
BMJ open, ISSN 2044-6055, 01/2018, Volume 8, Issue 1, pp. e019437 - e019437
diabetic foot ulcers | agreement | wound swab sample | diabetic foot infection | tissue sample | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pseudomonas Infections - etiology | Prospective Studies | Streptococcus - growth & development | Humans | Middle Aged | Pseudomonas aeruginosa - growth & development | England | Male | Wound Healing | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Staphylococcal Infections - microbiology | Foot - pathology | Diabetic Foot - complications | Streptococcal Infections - microbiology | Staphylococcal Infections - drug therapy | Cross-Sectional Studies | Pseudomonas Infections - drug therapy | Specimen Handling - methods | Pseudomonas Infections - diagnosis | Diabetic Foot - microbiology | Streptococcal Infections - etiology | Foot - microbiology | Pseudomonas Infections - microbiology | Staphylococcal Infections - diagnosis | Streptococcal Infections - diagnosis | Streptococcal Infections - drug therapy | Aged | Staphylococcus aureus - growth & development | Staphylococcal Infections - etiology | Microbiology | Laboratories | Infections | Standards | Studies | Antibiotics | Biopsy | Medical prognosis | Leg ulcers | Agreements | Diabetes | Foot diseases | Public health | Methods | Index Medicus
Journal Article
Plastic and reconstructive surgery (1963), ISSN 0032-1052, 04/2018, Volume 141, Issue 4, pp. 486e - 492e
Pseudomonas Infections - etiology | Escherichia coli Infections - prevention & control | Humans | Middle Aged | Gentamicins - administration & dosage | Pseudomonas Infections - prevention & control | Drug Carriers | Anti-Bacterial Agents - therapeutic use | Microspheres | Tissue Expansion - methods | Mammaplasty - methods | Mastectomy | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Escherichia coli Infections - etiology | Tissue Expansion Devices | Escherichia coli Infections - diagnosis | Surgical Wound Infection - epidemiology | Vancomycin - administration & dosage | Gentamicins - therapeutic use | Staphylococcus epidermidis - isolation & purification | Calcium Sulfate | Antibiotic Prophylaxis - methods | Pseudomonas Infections - diagnosis | Treatment Outcome | Tissue Expansion - instrumentation | Surgical Wound Infection - prevention & control | Escherichia coli Infections - epidemiology | Staphylococcal Infections - diagnosis | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Vancomycin - therapeutic use | Surgical Wound Infection - diagnosis | Staphylococcal Infections - prevention & control | Aged | Anti-Bacterial Agents - administration & dosage | Staphylococcal Infections - etiology | Index Medicus | Abridged Index Medicus
Journal Article